World health organization
This page is dedicated to providing information and updates about the World Health Organization (WHO) and its global initiatives. Our aim is to keep the general public informed about the WHO's efforts in addressing international health issues and promoting development. Stay informed about global health and development with HEALTHNDEVELOPMENT.

Global health and development
At HEALTHNDEVELOPMENT, we are committed to delivering professional, friendly, innovative, and experienced coverage of the WHO's activities. Explore our articles and resources to understand how the WHO contributes to global health and development, and how these efforts impact communities worldwide.

The WHO in action
Learn about the WHO's on-the-ground initiatives and partnerships aimed at improving health outcomes in developing nations. We provide in-depth analysis of their programs, funding, and impact, ensuring you stay informed about the latest developments in global health.

Healthndevelopment's coverage
We pride ourselves on delivering accurate and timely information about the WHO's strategies and achievements. Our coverage includes insights into policy changes, technological advancements, and collaborative efforts that drive progress in global health and development.
WHO Director-General visits Jordan to recognize strong collaboration on health system delivery, emergency relief and advancing mental health
WHO Director-General visits Jordan to recognize strong collaboration on health system delivery, emergency relief and advancing mental health
Dr Tedros meets with His Majesty King Abdullah II, key donors, Gaza children receiving treatment. Duke and Duchess of Sussex lend support to WHO’s humanitarian and mental health activities.
25 February 2026 - Amman: The Director-General of the World Health Organization, Dr Tedros Adhanom Ghebreyesus, today concluded the first day of his two-day State visit to the Hashemite Kingdom of Jordan, underscoring the strong partnership between WHO and Jordan across the areas of universal health coverage (UHC), mental health and humanitarian health action.
A central moment of the visit was today’s meeting with His Majesty King Abdullah II, reflecting the importance of this State visit and Jordan’s leadership in advancing health as a national and global priority. Discussions focused on strengthening health systems, expanding access to care, and sustaining support for emergency responses in the region, particularly for the Palestinian people, patients evacuated from Gaza to Jordan for treatment, and refugees hosted in Jordan.
“I wish to express my appreciation to His Majesty King Abdullah II for his commitment to advancing universal health coverage,” said Dr Tedros. “I also extend my thanks to His Majesty and the people of Jordan for their solidarity and generosity in providing health services to more than three million refugees, primarily from Gaza and Syria, who are living in the country.
Dr Tedros added: “We are grateful for Jordan’s broader humanitarian leadership, including His Majesty’s Medical Corridor initiative, which delivers critical care to ill and injured children from Gaza. Jordan continues to show the world what it truly means to put health and humanity first.”
During the day, Dr Tedros visited a WHO-supported hospital providing specialized care to children evacuated from Gaza. He met young patients and their families, as well as frontline health workers delivering life-saving treatment for injuries, cancer and other serious conditions. The visit highlighted the importance of the medical evacuation corridor through Jordan and the need for sustained international support to ensure children and others in need can access essential care.
The Director-General also convened a high-level meeting with health partners, donor countries, United Nations agencies and philanthropies to discuss financing priorities for health system strengthening in Jordan and ongoing humanitarian health action, including scaling up mental health services and supporting countries hosting large refugee populations. He welcomed the strong collaboration and continued commitment of partners to invest in health in Jordan and across the region.
He further held bilateral discussions with the Minister of Health, focusing on strengthening Jordan’s health system and advancing UHC. Jordan has demonstrated global leadership in strengthening a primary health care approach to achieve UHC including the integration of mental health, ensuring that people can access mental health services as part of routine care. WHO continues to support this work through the Director-General’s Special Initiative for Mental Health.
The Director-General was accompanied during several engagements by the Duke and Duchess of Sussex, Prince Harry and Meghan, in their capacities as founders of Archewell Philanthropies and long-standing supporters of WHO’s work. Archewell has supported WHO initiatives ranging from equitable access to COVID-19 vaccines to medical evacuation and mental health programmes. Prince Harry also participated as an ally of WHO’s work on mental health, highlighting the importance of investing in mental health across communities and emergency settings, with particular attention to men, young people and children.
Dr Tedros said: “I want to thank our partners, including Prince Harry, Duke of Sussex and Meghan, Duchess of Sussex, whose commitment to mental health and humanitarian action has helped bring visibility, resources and hope to some of the world’s most vulnerable communities. Their collaboration is helping to advance WHO’s mission to ensure health for all.”
Prince Harry said: “It is an honour to join the Director-General of the World Health Organization in Jordan, a country that is leading by example in compassion, resilience and innovation. Through our work with Archewell Philanthropies, my wife and I have seen first-hand the impact of WHO’s efforts to support mental health and deliver life-saving care in emergencies. We remain deeply committed to advancing awareness, reducing stigma and expanding access to mental health support for all those affected by conflict and crisis. Mental health is fundamental to recovery, dignity and long-term peace, and we are proud to stand with WHO and partners around the world to make it a global priority.”
During the second day of the visit, Dr Tedros will visit Jordan’s National Center for Rehabilitation of Addicts, which is supported by WHO and provides integrated medical, psychological and social services. He will also meet with community leaders and women’s groups, including the Jordanian Hashemite Fund for Human Development, and visit the King Hussein Cancer Center to discuss advances in cancer care and regional collaboration.
The State visit will conclude with additional engagements with partners supporting humanitarian operations, reinforcing Jordan’s critical role as a hub for medical evacuation, emergency response and health system resilience in the region.
JOINT NEWS RELEASE
Preventive cholera vaccination resumes as global supply reaches critical milestone
First preventive campaign in over three years launches in Mozambique, with others planned in Bangladesh and the Democratic Republic of the Congo
GENEVA/NEW YORK, 4 February 2026 | Global cholera vaccine supply has now increased to a level sufficient to allow the resumption of life-saving preventive campaigns for the first time in over three years, Gavi, the Vaccine Alliance, UNICEF, and the World Health Organization (WHO) announced today.
Mozambique is the first country to restart preventive vaccination, following the halt in 2022 caused by the global surge in cholera cases that drove up demand and led to shortages of oral cholera vaccine (OCV) stocks.
The preventive vaccination campaign begins amid an ongoing cholera outbreak and the aftermath of floods that affected more than 700 000 people and displaced many. The floods disrupted health systems and damaged water systems, further increasing the risk of waterborne diseases such as cholera.
“Global vaccine shortages forced us into a cycle of reacting to cholera outbreaks instead of preventing them. We are now in a stronger position to break that cycle. I thank EUBiologics, currently the only manufacturer producing cholera vaccines at the scale needed for mass vaccination campaigns, for its efforts, and urge others to enter this vital space. These vaccines will save lives,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General.
A first allocation of 20 million doses is being deployed for preventive campaigns. Of these, 3.6 million doses were delivered to Mozambique; 6.1 million to the Democratic Republic of the Congo that is also experiencing significant outbreaks; and 10.3 million doses are planned for delivery to Bangladesh.
Following sustained efforts by global agencies, manufacturers and partners, annual global supply of OCV has doubled from 35 million doses in 2022 to nearly 70 million doses in 2025. The doses are being financed by Gavi, and procured and delivered to countries by UNICEF.
“The multi-year surge in cholera cases and resulting unprecedented demand for vaccines were stark reminders that sustainable, accessible vaccine supply is a global public good – and the world cannot afford complacency,” said Dr Sania Nishtar, CEO of Gavi, the Vaccine Alliance. “We are grateful to our partners and manufacturers, particularly EUBiologics, for the collaboration that has made the resumption of these essential preventive campaigns possible, and to Gavi’s donors, whose support enables us to finance the global OCV stockpile and life-saving outbreak and preventive campaigns.”
“For the first time in years, this increase in vaccines will allow us to better prevent large-scale cholera emergencies,” said Catherine Russell, UNICEF Executive Director. “Resuming preventive cholera vaccination will protect children and help stop this highly contagious disease in its tracks. But it must go hand in hand with other efforts, including better access to safe water and basic sanitation.”
The three countries were chosen based on allocation criteria set out by the Global Task Force for Cholera Control (GTFCC), a partnership of over 50 organizations, to ensure cholera vaccines for preventive campaigns are distributed systematically, equitably and transparently.
“This milestone shows the power of bringing together diverse partners to build a more reliable response to cholera. Preventive vaccination helps shield communities and buys critical time. However, lasting progress will depend on long‑term investment in infrastructure, for which political commitment is indispensable,” said Dr Ilesh Jani, chair of the Steering Committee of the GTFCC.
The restoration of preventive vaccination has been made possible by years of sustained efforts and close collaboration among agencies, manufacturers, and other partners to meet the continued high demand to respond to outbreaks, expand production capacity and streamline allocation, ensuring that limited supplies reach the places where the risk and public health impact are greatest.
The OCV is safe and effective and is recommended for individuals over 1 year of age. One dose of OCV provides short-term protection for at least 6 months and can help bring outbreaks under control, while two doses provide protection against infection for longer - 3 years.
While global vaccine supply steadily improves, the one-dose strategy will remain the standard for outbreak responses, with the use of two doses considered on a case-by-case basis.
Cholera: continued surge
Cholera spreads through contaminated food and water, causing severe diarrhoea and dehydration. It can lead to death if it is not treated quickly. It is found in places without safe water and sanitation, mainly in localities affected by conflict and poverty.
More than 600 000 cases of cholera or acute watery diarrhoea and nearly 7600 deaths were reported to WHO from 33 countries last year, although these are underestimates as cholera remains underreported. Since 2021, global cholera cases have risen year after year, with a decline observed in 2025. Cholera deaths, however, have continued to increase over the same period.
Vaccination is only one aspect of cholera prevention and response. Long-term investments in safe water, sanitation and hygiene infrastructure, alongside disease surveillance, rapid treatment and community engagement, remain essential to prevent outbreaks from starting and spreading, and to reduce deaths in the long term.
#####
About Gavi, the Vaccine Alliance
Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate more than half the world’s children against some of the world’s deadliest diseases. The Vaccine Alliance brings together developing country and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry, technical agencies, civil society, the Gates Foundation and other private sector partners. View the full list of donor governments and other leading organisations that fund Gavi’s work here.
Since its inception in 2000, Gavi has helped to immunise a whole generation – over 1.2 billion children – and prevented more than 20.6 million future deaths, helping to halve child mortality in 78 lower‑income countries. Gavi also plays a key role in improving global health security by supporting health systems as well as funding global stockpiles for Ebola, cholera, meningococcal and yellow fever vaccines. After two decades of progress, Gavi is now focused on protecting the next generation, above all the zero-dose children who have not received even a single vaccine shot. The Vaccine Alliance employs innovative finance and the latest technology – from drones to biometrics – to save lives, prevent outbreaks before they can spread and help countries on the road to self-sufficiency. Learn more at www.gavi.org and connect with us on Bluesky, Facebook, Instagram, LinkedIn, TikTok, X and YouTube.
About UNICEF
UNICEF, the United Nations agency for children, works to protect the rights of every child, everywhere, especially the most disadvantaged children and in the toughest places to reach. Across more than 190 countries and territories, we do whatever it takes to help children survive, thrive, and fulfil their potential.
For more information about UNICEF and its work, please visit: www.unicef.org
Follow UNICEF on X (Twitter), Facebook, Instagram, and YouTube
About WHO
Dedicated to the well-being of all people and guided by science, the World Health Organization leads and champions global efforts to give everyone, everywhere an equal chance at a safe and healthy life. We are the UN agency for health that connects nations, partners and people on the front lines in 150+ locations – leading the world’s response to health emergencies, preventing disease, addressing the root causes of health issues and expanding access to medicines and health care. Our mission is to promote health, keep the world safe and serve the vulnerable. www.who.int
Monday, 2 February 2026
WHO Director-General's opening remarks at the 158th session of the Executive Board – 2 February 2026
https://www.who.int/news-room/speeches/item/who-director-general-s-opening-remarks-at-the-158th-session-of-the-executive-board-2-february-2026
Audio - https://who.canto.global/b/P77JG
Video - https://who.canto.global/b/I2UC1
Chair, Secretary Blair Comley,
Our vice-chairs, Honourable Ministers, Ambassadors, heads of delegation, members of the Executive Board, dear colleagues and friends,
Good morning and a warm welcome back to WHO – your WHO.
2025 was a year of stark contrasts for our Organization, as we all know.
On one hand, it was a landmark year:
the WHO Pandemic Agreement was adopted;
the amended International Health Regulations entered into force;
the next increase in assessed contributions was approved; and
the United Nations General Assembly adopted an ambitious political declaration on noncommunicable diseases and mental health.
On the other hand, it was undeniably one of the most difficult years in our Organization’s history.
Significant cuts to our funding left us with no choice but to reduce the size of our workforce.
Of course, WHO is just one part of a much bigger picture.
Many other international organizations have been affected.
And sudden and severe cuts to bilateral aid have also caused huge disruptions to health systems and services in many countries.
I am proud that despite the challenges we faced, there are many achievements to celebrate.
Allow me to highlight a few, according to each of the three key priorities of the Fourteenth General Programme of Work (GPW 14): to promote, provide and protect health.
First, our work to promote health and prevent disease by addressing its root causes.
In response to funding cuts, WHO is supporting many countries to sustain essential health services, and to transition away from aid dependency towards self-reliance, based on domestic resources.
One key tool for mobilizing domestic resources is health taxes.
That’s why WHO launched the 3 by 35 Initiative last year, calling on all countries to raise the real prices of tobacco, alcohol and sugary drinks by at least 50% by 2035.
Last year alone, Malaysia, Mauritius, Slovakia, Sri Lanka and Viet Nam were among countries that introduced or increased taxes on one or more of these products.
Already this year, India introduced a new excise duty on tobacco and Saudi Arabia introduced a tiered excise tax on sugary drinks.
On tobacco, the WHO Framework Convention on Tobacco Control celebrated its 20th anniversary last year.
Since the FCTC entered into force, tobacco use has dropped by one third globally, and continues to decline in 140 countries.
Last year, Maldives became the first country to adopt a generational tobacco ban for people born from 2007.
WHO also recognized Austria, Norway, Oman and Singapore for their efforts to eliminate trans fats from their food supplies.
The Commission on Social Connection delivered the first global evidence-based framework on loneliness and social isolation.
The WHO Alliance for Transformative Action on Climate and Health grew to more than 100 countries, helping them to build climate resilient, low carbon health systems.
Member States also endorsed an updated Global Road Map on Air Pollution and Health, including a commitment to halve health impacts by 2040.
And new data from the WHO/UNICEF Joint Monitoring Programme showed that one billion more people now have access to safely managed drinking water than a decade ago, saving an estimated 5 million lives.
===
Now to our work supporting countries to provide health, by strengthening health systems on the road to universal health coverage.
Following cuts to bilateral aid, WHO developed guidance on responding to the health financing emergency, supporting countries including Cambodia, Ethiopia, Mozambique and Uganda.
In December we established the UHC Knowledge Hub in Tokyo with the World Bank and the Government of Japan, which is now supporting the first cohort of eight countries through capacity-building, knowledge sharing, and by bringing ministries of health and finance together.
The latest UHC Global Monitoring Report shows that 4.6 billion people still lack access to essential health services, and 2.1 billion people face financial hardship because of health costs.
One of the main reasons people miss out on health services is because they don’t have access to a health worker. The world is facing a shortage of 11 million health workers by 2030, more than half of which is a shortage of nurses.
In response, last year WHO supported 11 countries facing the most acute shortages to strengthen their national workforce strategies, contributing to commitments for nearly 100 000 new health worker jobs.
With WHO’s support, South Africa has expanded its health workforce by 28% over the past five years.
Building the capacity of the global health workforce was one of the main reasons for establishing the WHO Academy in Lyon, with the support of the Government of France, which now brings together in one place our work on health workforce policy, strategy, data and advocacy, alongside learning.
The Academy now offers more than 250 courses free of charge, in up to 20 languages, with more than 100 000 enrolments last year.
I urge all Member States to make use of this resource. It is there for you.
One of the courses the Academy offers is the Basic Emergency Care programme, which provides standardized training on how to manage acutely ill patients.
A study of over 35 000 patients in 17 hospitals in Nepal, Uganda and Zambia showed a reduction in mortality of between 34% and 50% following the implementation of the WHO Academy Basic Emergency Care training.
===
We also continue to support countries to strengthen their health data systems, including through the use of digital technologies and artificial intelligence.
We expanded the Global Digital Health Certification Network to 82 countries, enabling 2 billion people to access their health records on national digital health wallets.
And we have now rolled out ICD-11 to 132 Member States. Every day, our ICD systems receive around 3 million requests for information, improving data quality ensuring generating insight into population health trends.
===
We also continue supporting countries to expand access to essential medicines.
Last year, we prequalified 44 medicines, nine vaccines, 10 in vitro diagnostics, 21 medical devices, eight vector control products, and we performed 185 inspections of manufacturing sites.
We updated the Essential Medicines List to include new medicines for cancer and GLP-1s for diabetes in people with obesity;
We reviewed 5000 pediatric formulations to prioritize those that are optimised and age-appropriate for children.
And we designated five more agencies as WHO Listed Authorities: Australia, Canada, Indonesia, Japan and the United Kingdom. This will help expedite regulatory processes and have medicines available in time.
In addition, we recognized Ethiopia for reaching maturity level 3 for regulatory oversight of medicines and vaccines;
And seven member states in the African region won a global UN award for their pooled procurement initiative, which was supported by WHO and has helped them to realise significant cost savings.
In addition, the World Health Assembly adopted the WHO Global Traditional Medicine Strategy and launched the Traditional Medicine Global Library, with over 1.6 million scientific records.
On antimicrobial resistance, the Global Antimicrobial Resistance and Use Surveillance System – GLASS – showed that 1 in 6 bacterial infections globally are now resistant to antibiotics, and the trend is increasing.
Concerningly, GLASS also shows that many countries are potentially accelerating resistance by using antibiotics that are in the “watch” category, when they could be using antibiotics in the “access” category.
In Kyrgyzstan, WHO supported a national survey that catalyzed a total shift in the national AMR plan.
And through the Special Programme for Research and Training in Tropical Diseases – TDR – we supported research on AMR that shaped national and regional strategies in Ghana, Colombia and Ecuador.
===
In addition to our work to strengthen the foundations of health systems, we also saw progress on our disease-specific programmes.
On maternal mortality, WHO released updated estimates that more than 55 high-burden countries used to refocus on proven interventions.
With partners, we issued the first consolidated guideline on postpartum haemorrhage, creating a single global clinical standard for the leading cause of maternal death that is saving lives when applied consistently.
We also issued our first global guideline on infertility, and published updated global estimates on violence against women.
===
On immunization, despite funding cuts we protected the Global Measles and Rubella Lab Network, enabling our network of more than 740 labs to process more than 700 000 tests to detect and respond to measles outbreaks globally.
We supported seven new countries to introduce malaria vaccines, bringing the total to 24;
And we supported 15 more countries to introduce HPV vaccination to prevent cervical cancer.
Since we launched the global call to action to eliminate cervical cancer in 2018, almost 75 countries have introduced HPV vaccination, meaning 65% of girls globally now live in a country with routine HPV vaccination.
In response to concerns about vaccine safety, WHO conducted an analysis of 31 studies in multiple countries over 15 years that showed once again that vaccines, including those containing thiomersal and aluminium adjuvants do not cause autism.
Vaccines are also bringing us closer to the eradication of polio, with 41 cases of wild polio reported last year from just 24 districts in Pakistan and Afghanistan, down from 99 cases in 49 districts in 2024.
In addition, Madagascar stopped its polio outbreak, and countries around Lake Chad mounted a joint vaccination campaign that reached more than 83 million children;
And with partners WHO vaccinated over 600 000 children in Gaza, controlling the Strip’s first recorded polio outbreak in 25 years.
2025 was another year in which more countries eliminated neglected tropical diseases.
Burundi, Egypt, Fiji, Mauritania, Papua New Guinea and Senegal eliminated trachoma, Guinea and Kenya eliminated sleeping sickness, and Niger became the first African country to eliminate river blindness.
In addition, WHO certified Georgia, Suriname and Timor Leste as malaria-free;
Maldives became the first country to achieve triple elimination of mother-to-child-transmission of HIV, syphilis and hepatitis B;
Brazil was validated for eliminating vertical transmission of HIV;
And Botswana reached gold tier status on the path to elimination.
WHO also prequalified lenacapavir for HIV prevention and published guidelines on its use, supporting the first 14 countries to accelerate the rollout of this new tool that could change the trajectory of the HIV epidemic.
Lenacapavir is the nearest thing we have to an HIV vaccine: a long-acting injectable antiretroviral taken every six months that has been shown to prevent almost all HIV infections in those at risk.
It’s the first example of a new approach to develop prequalification and guidelines in parallel, not in sequence, to speed up equitable access to innovative new tools.
On TB, WHO supported countries to scale up rapid TB diagnostics, and promoted shorter and more effective treatment regimens.
And the TB Vaccine Accelerator is working with countries to prepare for the rapid integration of new TB vaccines into health systems should they succeed in phase three trials.
===
On noncommunicable diseases, as I mentioned earlier, the UN General Assembly adopted the most ambitious political declaration yet, with concrete targets on tobacco, hypertension and mental health.
We also issued new guidelines on the use of GLP-1s for the treatment of obesity in adults;
And WHO initiatives on cervical, breast and childhood cancer are now benefiting over one million people in more than 100 countries.
In partnership with St Jude Children’s Research Hospital, we delivered 1.5 million cancer medicines, supporting treatment for 2400 children in five countries.
We also supported 14 more countries to strengthen mental health services for children and young people.
Since it launched in 2020, WHO’s Special Initiative for Mental Health has expanded mental health services to over 90 million people and enabled first-time treatment for more than 1.5 million children and adults.
And we supported 29 countries to scale up access to spectacles. As many of us know, including me, a pair of glasses can make a huge difference to quality of life.
===
Now to WHO’s work to support Member States to prevent, prepare for and respond to health emergencies.
This past Friday marked six years since I declared COVID-19 a public health emergency of international concern – and we closed that chapter in May 2023.
The pandemic taught all of us many lessons – especially that global threats demand a global response. Solidarity is the best immunity.
Most notably last year, Member States adopted the WHO Pandemic Agreement and the amended International Health Regulations entered into force.
WHO took many other steps last year to strengthen health emergency preparedness and response.
Through the Pandemic Fund with the World Bank, WHO supported countries to develop and implement 41 projects, helping 70 countries to strengthen surveillance, laboratory networks, workforce capacity and multisectoral coordination.
The WHO Hub for Pandemic and Epidemic Intelligence launched an update of the Epidemic Intelligence from Open Sources system – EIOS – which harnesses the power of AI to support more than 110 countries and 30 organizations, who use the platform every day to quickly identify new threats.
Through the International Pathogen Surveillance Network, over 110 countries are also strengthening genomic surveillance to better track pathogens, detect new variants, and guide faster responses to emerging threats.
The WHO BioHub coordinated 25 sample shipments to 13 laboratories in nine countries, to guide research and development of countermeasures.
Twenty countries completed joint external evaluations, 195 states parties submitted their annual IHR reports, and 22 countries completed their National Action Plan for Health Security.
The Global Influenza Surveillance and Response System – GISRS – processed more than 12 million samples.
And through the Pandemic Influenza Preparedness Framework – PIP – WHO signed eight new agreements, giving us access to more than 900 million vaccine doses in the event of an influenza pandemic, as well as antivirals, syringes and diagnostics.
To protect against outbreaks of yellow fever, we supported the vaccination of more than 38 million people in the Democratic Republic of the Congo, Guinea-Bissau, Niger and Uganda.
After a three year break we have also re-established preventive cholera vaccination, allocating 50 million doses to Bangladesh, DRC and Mozambique, thanks in part to a doubling of supply.
We supported preventative vaccination for Ebola for approximately 100 000 front line workers in the DRC and Central African Republic.
We also established a new stockpile for a monoclonal antibody against Ebola, with treatment courses ready to be shipped in 24 hours if an outbreak is confirmed.
Just as we supported countries to prevent and prepare for health emergencies, we also supported them to respond.
In 2025, WHO detected 1.2 million signals, assessed and verified about 500 threats, and supported countries to respond to 450 of those events, preventing disease spread and saving lives. You do not see this in the news because they were controlled, managed and contained.
In total we responded to 50 emergencies in 82 countries and territories last year.
We released US$ 29 million from the WHO Contingency Fund for Emergencies to support the rapid response to emergencies in 30 countries. Thank you to countries for contributing to the Contingency Fund for Emergencies.
And through the Global Outbreak Alert and Response Network – GOARN – we coordinated 59 deployments to support emergency response in 16 countries.
With WHO support, the DRC controlled an outbreak of Ebola virus disease within six weeks, and Tanzania and Ethiopia controlled outbreaks of Marburg virus disease.
And in September, I declared an end to mpox as a public health emergency of international concern.
Through the Access and Allocation Mechanism, WHO secured three million doses of mpox vaccine, supporting the vaccination of two million people.
We also continued to respond to the global resurgence of cholera, deploying more than 50 million doses of oral cholera vaccine from the global stockpile.
We also launched the first WHO guidelines for the diagnosis and treatment of meningitis, and supported the response to meningitis outbreaks with 4 million doses of vaccine.
In addition to outbreak response, we also responded to the health needs of more than 25 million people affected by humanitarian emergencies in 33 countries.
In Gaza, we organized the transport and shipment of 938 trucks of lifesaving emergency health supplies, coordinated more than 80 Health Cluster partners, and supported over 8000 medical evacuations.
In Sudan, since the start of the conflict in 2023, we have delivered almost 3000 metric tons of medical supplies, responded to outbreaks of cholera, dengue and malaria, and we are providing direct support to dozens of hospitals, primary health care centres, mobile clinics and nutrition centres.
In Ukraine we deployed 17 mobile teams, which provided more than 18 500 health consultations in more than 140 locations. We also supported the medical evacuation of more than 6200 patients, and provided mental health training to more than 150 000 health workers.
In all these places, we continue to see attacks on health care as the alarming and illegal new normal of conflict.
In 2025, WHO verified 1350 attacks on health care in 19 countries and territories, causing 1981 deaths and 1168 injuries among health workers and patients.
Of course, WHO does not work alone. As the Health Cluster lead of the UN Inter-Agency Standing Committee, we coordinate over 1500 partners, who reached 32 million people with humanitarian assistance last year.
We also coordinated the deployment of more than 100 international emergency medical teams, who provided 1.8 million medical consultations in more than 20 countries.
===
In addition to all of this work to promote, provide and protect health, the Secretariat supported work on the fourth and fifth Ps of GPW 14: to power and perform for health, through science, digital technologies, data and our ongoing Transformation.
Last year, we launched a new global action plan and a new global network to strengthen clinical trials, with 34 major research institutions, advancing equitable research capacities around the world.
We also launched a three-year project to modernize the way WHO prioritizes, develops and disseminates our highest-priority guidelines.
Through the Alliance on Health Systems Policy and Research, we’re supporting Sri Lanka to establish its Centre for Disease Control and to shape its National Health Policy for the next decade.
And this year we are celebrating 25 years of Research4Life and Hinari, which makes scientific publications available for free or at very low-cost in low- and middle-income countries, facilitating access to promote evidence-based policies.
===
Meanwhile, we continue to take steps to make WHO more accountable, transparent, efficient and effective.
WHO’s Office of Internal Oversight Services completed 13 country office audits, two regional office audits and two cross cutting-audits in 2025. There were no unsatisfactory conclusions.
We expanded our evaluation function and improved completion rates;
And our investigations function handled 1174 cases and closed 636 cases in 2025. The year end caseload fell to 538, which is the lowest in three years. The number of substantiated cases rose to 45.
This year we are introducing a new case management system with AI capability, and a new integrity hotline. Both will help to strengthen timely, high-quality investigations and provide safer channels for reporting, strengthening our internal justice.
The Regional Office for Africa also hosted the first WHO Strategic Conference on Prevention and Response to Sexual Misconduct in joint WHO–Member State operations, with 42 Member States.
And for the first time, Member States agreed to include a gender equality indicator in the results framework in GPW 14.
===
Excellencies, dear colleagues and friends,
I hope you will agree that despite the many challenges we have faced, your Organization has continued to deliver.
None of these achievements would have been possible without WHO’s people – my colleagues.
Throughout 2025, they continued to serve you with dedication and commitment, even though many of them were uncertain as to whether they would still have a job.
I will remember 2025 – as we all should – for them.
I express my deep gratitude to all staff who have left or are leaving for their service and dedication.
Of course, no process is perfect, and we acknowledge the legitimate concerns that some staff have raised about it.
We take those concerns seriously, we have addressed many of them and we continue to do so.
We have designed, communicated and implemented the changes we have made based on the principles of transparency, fairness and humanity. By and large, the outcome was good.
Although there are still a few issues to finalize, we have now largely completed the prioritization and realignment.
We have reached a position of stability and we are moving forward.
It’s important to remember that although the cuts we faced last year were a shock, they were a shock we saw coming, and for which we have been preparing.
When we began the WHO Transformation more than eight years ago, we identified our over-reliance on a handful of donors as a major risk, and we took several measures to address it.
Most significantly, we proposed – and in 2022 the World Health Assembly approved – a plan to progressively increase assessed contributions to 50% of the base budget, from just 14% at the time.
Member States approved the first increase in May 2023, the second increase last year, May 2025, and the next three increases are scheduled for approval in May 2027, May 2029 and May 2031.
We also took a series of other steps to broaden our donor base, including by establishing the WHO Foundation and conducting our first Investment Round, with your support.
Thanks to all these measures, we have now mobilized 85% of the resources we need for the base budget this biennium, 2026–27.
At one level, we are in a better position than ever before at this stage of a biennium.
However, because the majority of voluntary contributions remain earmarked, we continue to see pockets of poverty, including for our work on emergency preparedness, AMR, health financing, climate resilience, determinants of health and more.
And although 85% sounds good – and it is – the environment is very difficult and the remaining 15% will be hard to mobilise.
If you had not approved the increase in assessed contributions, we would have been in a far worse situation than we are.
This demonstrates why Member States must continue on the same path and approve the remaining increases, to secure the long-term stability, sustainability and independence of WHO – not only until 2031 but even beyond.
When I say independence, I don’t mean independence from Member States, of course. WHO belongs to you, and always will.
I mean non-dependence on a handful of donors;
I mean non-dependence on inflexible, unpredictable funding;
I mean a WHO that that is no longer a contractor to the biggest donors;
I mean an impartial, science-based organization that is free to say what the evidence says, without fear or favour.
Although we have faced a significant crisis in the past year, we have also viewed it as an opportunity.
It’s an opportunity for a leaner WHO to become more focused on its core mission and mandate, including in the context of the UN80 reform initiative.
This means sharpening our focus on our core mandate and comparative advantage, doing what we do best – supporting countries through our normative and technical work – and leaving to others what they do best.
WHO can’t do everything, and we shouldn’t try.
WHO’s superpower is its convening power – the ability to bring together governments, experts, institutions, partners, civil society and the private sector under one umbrella.
Our success – and yours – lies in harnessing that power, including through our network of more than 800 collaborating centres – a powerful resource for strengthening our normative work and ensuring that evidence drives policy.
After all, the needs of the countries we serve are always evolving, so WHO must also continue to evolve.
That means that the governance of WHO must evolve.
If we want an agile, efficient and effective Secretariat, we need agile, efficient and effective governance. I hope you will support the Chair in the governance reform he proposed.
If we want a Secretariat that can deliver on Member State priorities, we need Member States to prioritize, and to resource those priorities.
This is your WHO – it is what you want it to be, and what you make it.
And as WHO evolves, so must the global health architecture – or as I prefer to say, the global health ecosystem.
There are now many discussions on reforming that ecosystem to ensure all partners leverage their comparative advantage, avoid overlaps and duplication, and that together we deliver value and results for the countries we serve.
We are proposing to bring those discussions together into a joint process to help transition to a leaner, more collaborative and impactful global health ecosystem, in support of country priorities.
We look forward to your advice and guidance on that and the other agenda items before you this week.
===
Excellencies, dear colleagues and friends,
We can see the difficulties of the past year as a setback, or we can choose to see them as the catalyst for the future of WHO.
The path forward is clear. It is the path we have already charted; it is the foundation we have already laid in the Transformation and the realignment:
To secure our financial stability and sustainability;
To strengthen our normative and technical leadership;
To reform our governance;
To reshape the global health ecosystem;
To leverage our collective strengths;
To reinforce our solidarity;
And to do it all in service of country-led priorities – your priorities.
That’s why you founded WHO in the first place – to create a place where the nations of the world work together to find shared solutions to shared threats.
That’s why you adopted the Pandemic Agreement last year;
And that’s why you are now negotiating the PABS Annex, and I am confident that you will conclude your negotiations in time for this year’s World Health Assembly.
The story of 2025 is not one of austerity but resolve.
It is the story of the people of this Organization serving the people of this world.
They are the reason WHO is here, and the reason we will continue to be here.
This is your WHO. Its strength is your unity. Its future is your choice.
I thank you.
WHO Director-General's opening remarks at the ACANU media briefing – 11 December 2025
Friday, 19 December 2025
WHO Director-General's closing remarks at the second WHO Global Summit on Traditional Medicine
https://www.who.int/news-room/speeches/item/who-director-general-s-remarks-at-the-closing-of-the-second-global-summit-on-traditional-medicine-19-december-2025
Your Excellency Prime Minister Modi,
Excellencies, Ministers, distinguished leaders, dear colleagues and friends,
Namaste.
I extend my deepest appreciation to the Government and people of India – and in particular to Prime Minister Modi – for hosting this Summit, and for his unwavering, continued leadership and partnership.
Your Excellency, your vision of “One Earth, One Health” encapsulates the principles of traditional medicine:
Balance between people and nature;
An emphasis on prevention over cure,
And health as a shared responsibility.
It aligns powerfully with WHO’s mission to promote health equity, sustainability, and resilience.
Under your leadership, India has helped to elevate traditional medicine in the global health agenda, and it’s now clearly on the global map.
From the establishment of a dedicated Ministry of Ayush, to the creation of the WHO Global Traditional Medicine Centre in Jamnagar, India has shown that tradition and innovation, heritage and science can advance together.
Through its centuries-old Ayush systems, India has shown the world that traditional wisdom and modern science are not inconsistent, but complementary.
Over the past three days, voices from more than one hundred countries have come together – scientists and practitioners, Ministers and Indigenous leaders, innovators and communities.
You have come from different traditions and different systems, but with one shared purpose: to bridge ancient tradition and modern science.
Together, you have shown that traditional medicine is not a relic of the past. It is not an alternative at the margins.
It is a living science, a shared heritage, and an important element of universal health coverage, resilient health systems, and sustainable development.
Traditional medicine can help to address many of the threats to health of our modern world: the growing burden of noncommunicable diseases; inequitable access to health services; and climate change.
It can help to support care that is person-centred, culturally grounded, and holistic.
Through the Delhi Commitment, countries have agreed not only on why traditional medicine matters – but on how to act.
We have agreed to strengthen the evidence base, using rigorous, ethical, and pluralistic research that respects whole systems and Indigenous knowledge;
We have agreed to ensure safety, quality, and public trust, through coherent and risk-based regulation;
We have agreed to safeguard biodiversity and traditional knowledge, while respecting cultural heritage, intellectual property, and equitable benefit-sharing;
We have agreed to harness digital technologies and innovation responsibly, to improve access, research, and data generation;
And we have agreed to integrate safe and effective traditional medicine into health systems, especially primary health care, where it delivers clear, evidence-informed value.
These priorities are at the heart of the WHO Global Traditional Medicine Strategy 2025 to 2034 – a strategy grounded in science, guided by ethics, and driven by equity and global solidarity.
Today, we also marked a historic step forward with the launch of the WHO Global Traditional Medicine Library.
This Library is far more than a repository of knowledge.
It is a platform of trust.
It will protect intellectual property and community rights;
Support equitable access and benefit-sharing;
And enable evidence-informed policy, education, and innovation – globally and across generations.
It is a powerful response to the call issued by Prime Minister Modi for global stewardship of traditional knowledge – a call echoed across the G20, BRICS, and beyond.
Prime Minister, Excellencies,
The real success of this summit will be measured not by what we agreed here in New Delhi – but by what happens next, in countries and communities.
That means translating commitments into national policies and regulatory frameworks;
It means investing in research, education, and workforce development;
It means integrating traditional medicine responsibly and safely into health systems;
And it means ensuring tangible, equitable benefits for people – especially those most underserved.
And I was very encouraged to hear all of the ministers of health who have been sharing their experiences during the Ministerial Roundtable, and of course, the heads of delegation.
WHO stands fully committed to walking this path with you – through the Global Traditional Medicine Centre, technical cooperation, shared standards, and transparent accountability.
But your message today was very clear at the Ministerial Roundtable.
As we conclude this summit, let us leave united by a shared conviction:
That the future of health must be integrative, inclusive, and evidence-informed.
That science and tradition are not opposites – but partners.
And that by restoring balance between people, communities, and the planet, we can build healthier societies for generations to come.
Prime Minister Modi’s leadership has helped bring this vision to the world stage.
Your Excellency, I look forward to your reflections and guidance as we move from commitment to action.
Thank you for your leadership.
Thank you for your partnership.
And thank you for shaping this future – together.
Bahut bahut dhanyawad.
WHO Director-General's opening remarks at the ACANU media briefing – 11 December 2025
Good afternoon and welcome once again to our friends from ACANU. Thank you for your continued interest in the work of WHO.
In 1998, a study was published in The Lancet that purported to show a link between vaccines and autism spectrum disorders.
The study was later shown to be fraudulent and retracted, but the damage had been done, and the idea has never gone away.
Today, WHO is publishing a new analysis by the Global Advisory Committee on Vaccine Safety that has found, based on available evidence, no causal link between vaccines and autism.
The committee looked at 31 studies in multiple countries over 15 years relating to vaccines containing thiomersal and aluminium adjuvants, and the association between vaccines and autism in general.
The committee concluded that the evidence shows no link between vaccines and autism, including vaccines containing aluminium or thiomersal.
This is the fourth such review of the evidence, following similar reviews in 2002, 2004 and 2012. All reached the same conclusion: vaccines do not cause autism. Vaccines cause adults.
Over the past 25 years, under-five mortality has dropped by more than half, from 11 million deaths a year to 4.8 million, and vaccines are the major reason for that.
Vaccines are among the most powerful, transformative inventions in the history of humankind.
Vaccines save lives from about 30 different diseases, including measles, cervical cancer, malaria and more.
Like all medical products, vaccines can cause side effects, which WHO monitors. But autism is not a side effect of vaccines.
Vaccines are essential not just for protecting children, but also for protecting adults against diseases including COVID-19 and influenza.
The northern hemisphere is currently experiencing its annual flu season.
Although the level of flu activity globally is within the normal range, since August, WHO has observed the emergence and rapid increase in circulation of so-called K subclade viruses of H3N2 influenza.
Although the data do not show an increase in disease severity, this subclade marks a notable evolution in H3N2 viruses.
Vaccines remain essential, especially for people at high risk of influenza complications and their care givers.
The same is true for COVID-19. Although the global impact of COVID-19 has reduced since the peak of the pandemic, the virus continues to spread, causing severe disease and death in high-risk groups, and post-COVID-19 condition, or “long COVID”, in about 6% of those it strikes.
The virus also continues to evolve. Last week, WHO designated a new variant under monitoring, BA.3.2, and published a new risk evaluation.
Last week, WHO also published a new strategic plan for coronavirus disease threats including COVID-19, MERS, and potential new coronavirus diseases.
This is the first unified plan for coronavirus disease threats, marking a turning point in the transition from the COVID-19 emergency response to sustained, long-term, and integrated management.
===
Immunization is one of the essential health services that should be covered as part of every country’s journey towards universal health coverage, or UHC.
Last Saturday, WHO and the World Bank launched the latest edition of the UHC Global Monitoring Report, which provides a snapshot of progress towards UHC.
It shows that since 2000, the world has made good progress towards UHC, with levels of access to health services and financial protection from out-of-pocket health spending both improving by about one third.
However, in recent years, progress has stalled.
The latest data show that 4.6 billion people still lack access to essential health services, and 2.1 billion people–more than one in four globally–face financial hardship because of health costs.
Tomorrow marks UHC Day. Around the world, WHO is working in many countries to support them to expand access to services and to reduce financial hardship from out-of-pocket health spending.
===
As you know, 2025 has been a year of significant achievements and significant challenges for WHO and global health in general.
The standout achievement of the year was the World Health Assembly’s adoption of the WHO Pandemic Agreement – a landmark achievement that will help to keep the world safer from future pandemics.
Member States are now negotiating an annex to the Pandemic Agreement, the Pathogen Access and Benefit Sharing system – PABS – to ensure rapid detection and sharing of pathogens with pandemic potential, and equitable and timely access to vaccines, therapeutics and diagnostics.
We are hopeful that the negotiations will be completed in time for the PABS annex to be adopted at next year’s World Health Assembly, so the Pandemic Agreement can be opened for signature and finally enter into force as international law.
Also this year, the amendments to the International Health Regulations came into force, strengthening global health security in several ways.
2025 also saw several countries confirmed for the elimination of diseases.
With WHO support, Maldives became the first country to achieve “triple elimination” of mother-to-child transmission of HIV, syphilis and hepatitis B.
Burundi, Egypt, Fiji, Mauritania, Papua New Guinea and Senegal eliminated trachoma, Guinea and Kenya eliminated sleeping sickness, and Niger became the first African country to eliminate river blindness.
In addition, Georgia, Suriname and Timor-Leste were certified as malaria-free, and seven new countries introduced WHO-approved malaria vaccines, bringing the total number to 24.
On HIV, WHO prequalified injectable lenacapavir and published guidelines on its use, to accelerate the rollout of this exciting new tool for HIV prevention that could change the trajectory of the epidemic.
On noncommunicable diseases and mental health, Member States at the UN General Assembly approved an ambitious Political Declaration, with concrete targets for the next five years. We look forward to its adoption by the General Assembly next week.
And just this month, we published new guidelines on the use of GLP-1 therapies for the treatment of obesity.
2025 was also a demanding but successful year for WHO’s work responding to emergencies around the world.
In total, we responded to 48 emergencies in 79 countries, providing essential health services to more than 30 million people;
We released US$ 29 million from the Contingency Fund for Emergencies to respond rapidly to 24 emergencies in 30 countries.
We supported Uganda and DRC to stop outbreaks of Ebola, Senegal and Mauritania to stop outbreaks of Rift Valley fever, Rwanda to stop an outbreak of Marburg, and we are currently supporting Ethiopia to respond to its outbreak of Marburg.
We shipped a record 56 million doses of cholera vaccines to respond to outbreaks in 14 countries;
We declared an end to mpox as a public health emergency of international concern;
And we provided lifesaving support in multiple humanitarian emergencies.
In Gaza, over the past two years we delivered more than 2500 metric tons of medical supplies and 18 million litres of fuel to hospitals, ambulances and health partners, and supported over 10 600 medical evacuations to 30 countries.
In Sudan, since the start of the conflict in 2023, we have delivered almost 3000 metric tons of medical supplies, responded to outbreaks of cholera, dengue and malaria, and we are providing direct support to dozens of hospitals, primary health care centres, mobile clinics and nutrition centres.
In Ukraine, we deployed 17 mobile teams, which provided more than 18 500 health consultations in more than 140 locations. We also supported the medical evacuation of more than 6200 patients, and provided mental health training to more than 150 000 health workers.
One of the many challenges we face in Gaza, Sudan, Ukraine and elsewhere is the appallingly high number of attacks on health care.
So far this year, WHO has verified 1272 attacks in 18 countries and territories, causing almost 2000 deaths and more than 1100 injuries.
Just yesterday, a health facility in Myanmar was attacked, killing 33 people and injuring 20.
Attacks on health care are violations of international law for which almost no one is ever held accountable.
WHO calls on all combatants in all countries to protect health care, in line with their obligations under international law.
===
As you know, 2025 has also been a year of significant challenges for global health and for WHO.
Steep cuts in development assistance have caused severe disruptions to health services in many countries.
Early estimates are indicating that childhood mortality could increase for the first time this century.
WHO has been supporting countries to maintain services, and to transition away from aid dependency towards sustainable self-reliance, based on domestic resources.
In the short-term, WHO is supporting countries to develop affordable essential health benefit packages;
To introduce or increase health taxes on tobacco, alcohol and sugary drinks;
And to strengthen domestic manufacturing, pooled procurement and other initiatives.
In the longer term, countries can strengthen risk-sharing mechanisms to improve financial protection, including through publicly-financed health insurance.
At the same time, WHO has also been affected, as you know.
The announcement by the United States of its intention to withdraw from WHO, combined with funding cuts from other countries, left us facing a salary gap for the next two years of about US$ 500 million.
In response, we tightened our belts and undertook a major prioritization and realignment exercise, which we have now almost completed.
Unfortunately, we had no choice but to reduce significantly the size of our global workforce.
This has been a crisis long in the making. Beginning in the 1980s, WHO has become increasingly dependent on voluntary, earmarked contributions from a small number of donors.
As part of the WHO Transformation over the past eight years, we have taken several steps to mitigate that dependence.
Most significantly, in 2022 WHO proposed – and Member States approved – a plan to increase assessed contributions progressively to 50% of the base budget, from just 14% at the time.
This is very historic, because in the history of the organization, the biggest increase was 3%.
The first increase was approved in 2023, the second was approved at this year’s World Health Assembly, and there are a further three increases planned for May 2027, May 2029 and the last one, May 2031.
If completed, this will be a major step towards WHO’s long-term stability, sustainability and independence, and preventing shocks like the current one.
Saying goodbye to so many dedicated and talented colleagues has been very difficult for all of us.
But the world continues to need WHO, and we remain committed to the vision the nations of the world had when they founded this organization in 1948: the highest attainable standard of health – not as a luxury for some, but a right for all.
Thank you all once again for your interest in WHO’s work.
Fadéla, back to you.
WHO Director-General's opening remarks at the media briefing – 1 December 2025
Good morning, good afternoon and good evening.
First, some good news: today marks the end of the most recent outbreak of Ebola virus disease in the Democratic Republic of the Congo.
I send my warmest congratulations to the government and people of the DRC, especially in the affected community of Bulape.
The outbreak was declared in September and there were 64 confirmed and probable cases, with 45 deaths.
We honour the memory of those who died, especially those who lost their lives while serving others.
WHO is proud to have played our part in bringing this outbreak under control, in support of the Ministry of Health, national public health institutions, and alongside our partners.
It’s important to remember how far we have come in our fight against Ebola.
When Ebola devastated West Africa a decade ago, there were no approved vaccines or therapeutics against it. Now we have both.
Ebola is a preventable and treatable disease that can be stopped.
And although Ebola has been stopped in DRC, an outbreak of Marburg virus disease was declared in Ethiopia over two weeks ago.
So far, 12 confirmed cases have been reported, including eight deaths. Three patients have recovered, and one is still under treatment.
The government of Ethiopia is leading the response, and WHO is supporting as requested.
We’re providing testing supplies and protective equipment for health workers, and deploying experts to support local authorities.
===
Now to Asia, where floods have caused devastation in Indonesia, Malaysia, Sri Lanka, Thailand and Viet Nam. Other countries in the region are also at risk.
More than 400 people have died in Indonesia, 160 in Thailand, 90 in Viet Nam and 300 in Sri Lanka, with hundreds more missing.
The floods have caused landslides, major damage to critical infrastructure, displacement, and severe disruption to essential services and livelihoods.
WHO is deploying rapid response teams and critical supplies, strengthening disease surveillance and supporting continuity of essential health services for affected communities.
It’s another reminder of how climate change is driving more frequent and more extreme weather events, with disastrous effects.
===
Now to our main news of the day.
Obesity is one of the most serious public health challenges of our time.
Globally, more than one billion people are living with obesity, and that number is expected to double by 2030.
Obesity is a chronic, relapsing disease that drives heart disease, diabetes, and some types of cancer.
It is linked with 3.7 million deaths globally a year, and puts huge strain on health systems and economies.
In recent years, a class of drugs called glucagon-like peptide-1 receptor agonists – or GLP-1s – which were originally developed to treat diabetes, have been approved in many countries for the treatment of obesity.
In September of this year, WHO added GLP-1 to the Essential Medicines List for the treatment of diabetes in high-risk groups.
Today we are issuing new recommendations on the use of GLP-1 to treat obesity in adults.
These new medicines are a powerful clinical tool, offering hope to millions.
But let me be clear: medication alone will not solve the obesity crisis.
Obesity is a complex disease that requires comprehensive, lifelong care.
And it has many social, commercial and environmental determinants, requiring action in many sectors – not only in the clinic.
This guideline is about integration. These therapies are part of a holistic strategy built on three pillars:
First, creating healthier environments through robust policies;
Second, protecting individuals at high risk through screening and early intervention;
And third, ensuring access to lifelong, person-centred care for those living with obesity.
Crucially, the use of GLP-1 does not replace the need for healthy diet and physical activity.
Our recommendation is conditional, and we acknowledge the challenges: we need more long-term data, the costs are high, and health systems are not yet ready.
Our greatest concern is equitable access.
Without concerted action, these medicines could contribute to widening the gap between the rich and poor, both between and within countries.
We must work together on strategies like pooled procurement and tiered pricing to make these medicines affordable for all.
This guideline is a key part of WHO’s Acceleration Plan to Stop Obesity.
It is built on evidence and shaped by the principle of health for all – ensuring that scientific progress benefits everyone, everywhere.
This guideline has been developed in response to strong demand from Member States and civil society.
So today I am very pleased to welcome three special guests.
First, it’s my privilege to welcome Dr Lackram Bodoe, the Honourable Minister of Health from Trinidad and Tobago.
Minister Bodoe, thank you for making the time to join us today. You have the floor, Your Excellency.
[MINISTER BODOE ADDRESSED THE MEDIA]
Thank you, Minister Bodoe. It’s now my pleasure to welcome Dr Jeanette Hunter, the Deputy Director-General of Primary Health Care at the National Department of Health in South Africa.
Dr Hunter, you have the floor.
[DR HUNTER ADDRESSED THE MEDIA]
Thank you Dr Hunter. I’m now pleased to welcome Dr Karen Sealey, a member of the Board of Trustees of the World Obesity Federation.
Dr Sealey, thank you for joining us today. You have the floor.
[DR SEALEY ADDRESSED THE MEDIA]
Thank you Dr Sealey, and thank you once again to all our guests for joining us today.
===
Finally, today is World AIDS Day.
Over almost 45 years, we have come a long way in the response to HIV.
New HIV infections have dropped by 61% since the peak in 1996, and AIDS-related deaths have dropped by 70% since 2004.
HIV has been transformed from a certain death sentence into a preventable and treatable disease.
But those gains are now at risk.
Sharp reductions in international funding this year have led to disruptions in services for HIV prevention, testing and treatment.
At the same time, progress against HIV has largely stalled. There were 1.3 million new HIV infections last year, the same number as the previous two years.
We face significant challenges, but we also have significant opportunities.
Earlier this year, WHO recommended and prequalified lenacapivir, a new long-acting injectable for the prevention of HIV.
This is the first time that guidelines have been published in parallel with prequalification, to accelerate access.
WHO calls on all countries to rapidly scale up use of lenacapivir for people at risk of HIV, as well as access to testing and treatment for those living with HIV but who may not know it yet.
Our ambition is not modest, but it is achievable: to end the AIDS epidemic.
Fadéla, back to you.
Related
WHO Director- General's opening remarks at the media briefing -23 October 2025
Thursday, 23 October 2025
WHO Director- General's opening remarks at the media briefing -23 October 2025
Good morning, good afternoon and good evening.
The ceasefire announced in Gaza two weeks ago is fragile and has been violated, but continues to hold, which is great news for everyone.
We welcome the return of hostages, the release of prisoners, the cessation in violence and the increase in aid flows.
But the crisis is far from over and the needs are immense.
More than 170 000 people have injuries in Gaza, including more than 5000 amputees, and 3600 people with major burns.
At least 42 000 people have injuries that require long-term rehabilitation.
And every month, 4000 women give birth in unsafe conditions.
Hunger and disease have not stopped, and children’s lives are still at risk.
The destruction has been physical but also psychological. An estimated one million people need access to mental health care.
The demands on the health system are huge, but significant parts of the system have been destroyed or badly degraded.
There are no fully functioning hospitals in Gaza, and only 14 out of 36 are functioning at all. There are critical shortages of essential medicines, equipment and health workers.
Since the ceasefire took effect, WHO has been sending more medical supplies to hospitals, deploying additional emergency medical teams, and scaling up medical evacuations.
Today, WHO teams are at the Kerem Shalom crossing, collecting medical supplies.
And yesterday, we supported the evacuation of 41 patients and 145 companions to several countries.
I thank the more than 20 countries who have received medical evacuees from Gaza.
However, there are still 15 000 patients who need treatment outside Gaza, including 4000 children. More than 700 have died while waiting for evacuation.
We continue to call for the restoration of referrals to the West Bank, including East Jerusalem;
We call for more countries to receive patients from Gaza for specialized care;
And we call for the Rafah crossing – and all crossings – to be opened, to allow more patients to be treated in Egypt, and to enable the scale-up of aid.
Although the flow of aid has increased, it’s still only a fraction of what is needed.
The Rafah crossing was supposed to be opened last week. A significant amount of aid has built up at Al-Arish in Egypt that is ready to enter Gaza as soon as the crossing is opened.
While we are focusing on responding to today’s health needs on the ground, we are also working with partners to plan for the longer-term recovery and reconstruction of Gaza’s health system.
Over the next days and weeks, WHO will focus on four areas:
First, maintaining life-saving and life-sustaining essential health services;
Second, strengthening public health intelligence, early warning, and prevention and control of communicable diseases;
Third, coordinating health partners;
And fourth, supporting the recovery, rehabilitation and reconstruction of the health system.
Our 60-day ceasefire plan asks for US$ 45 million, but the total costs for rebuilding Gaza’s health system will be at least US$ 7 billion dollars.
WHO was in Gaza before the war started, we have been there throughout, and we will stay there to help the people of Gaza build a healthier, safer and fairer future.
===
There’s more good news in the Democratic Republic of the Congo, where the Ebola outbreak seems to be on track to come to an end.
Last Sunday, the last patient with Ebola was discharged in Bulape, after making a full recovery.
The 42-day countdown started officially on Monday, meaning that if no further cases are confirmed, the outbreak will be declared over in early December.
In total, 64 cases have been reported, with 45 deaths and 19 recoveries.
This illustrates again what a dangerous disease Ebola is.
But it also shows that with strong government leadership, and the right tools, partnerships, and expertise, Ebola can be controlled swiftly.
The outbreak is not over yet. Measures on the ground need to be maintained so that we are ready to respond to any new cases.
More than 250 community health workers are following up contacts every day.
Some of them walk for hours through forests and swamps to reach the most isolated villages.
Since the start of the outbreak, almost a thousand alerts of potential Ebola cases have been reported, many coming from communities themselves, showing the importance of working hand-in-hand with affected populations.
The response in Bulape also relies on strong community mobilization, with community leaders briefing their people, including at markets and churches, to raise awareness about vaccination and isolation, and reinforce trust in the response.
WHO has deployed over 100 experts, providing 150 tons of medical supplies, ambulances, motorbikes and digital tablets for rapid data collection and sharing.
We’re also supporting the government to ensure that people who have recovered have continuing care through a survivor care programme.
===
Responding to emergencies is just one part of WHO’s work; supporting countries to prepare for them is another.
Today, WHO is publishing our new National Health Emergency Alert and Response Framework, which outlines the key steps for an effective and coordinated emergency response locally and nationally.
That includes dedicated systems with clear roles; a trained workforce; flexible procedures to deal with rapidly changing information; and more.
The framework has been developed based on lessons learned from real-world experiences, including the COVID-19 pandemic.
===
Finally, tomorrow is World Polio Day.
When we launched the Global Polio Eradication Initiative in 1988, more than 350 000 children were paralyzed by polio every year.
Today, that number has dropped by more than 99 percent – just 36 cases of wild poliovirus reported so far this year.
A large part of this success is due to the leadership of Rotary International, who have been pathfinders for polio elimination.
This week I had the opportunity to welcome partners from Rotary here at WHO, and to thank them for their partnership in bringing us so far.
But we’re not done, and as long as polio exists anywhere, it’s a threat everywhere.
Decades ago, the world overcome geopolitical and geographic barriers to end smallpox.
Let's do the same for polio. Let's finish the job.
REF 1 https://www.who.int/news-room/speeches/item/who-director-general-s-opening-remarks-at-the-media-briefing---23-october-2025